Read the latest Presentations from Asarina Pharma, containing full details of Sepranolone, our first-in-class therapy for PMDD, our science, pipeline and business intelligence.
Asarina Pharma presentation at Pareto September 2019 (pdf)
Asarina Pharma presentation at AGM May 2019 (pdf)

Meet our CEO Peter Nordkild, COO Karin Ekberg and CBO Otto Skolling as they present to investors in Stockholm, Gothenburg and online.

Press Kit

Access a range of resources on the Asarina Pharma team and offering.

The team

Management team
Scientific Advisory board

Company Logos

Image bank